Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672245 | SCV000797336 | uncertain significance | Ataxia-telangiectasia syndrome | 2018-01-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001187884 | SCV001354796 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-06 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000672245 | SCV002335726 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003153797 | SCV003842535 | likely benign | not provided | 2023-03-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Myriad Genetics, |
RCV004588100 | SCV005083009 | likely benign | Familial cancer of breast | 2024-05-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752]. |